(Q33610775)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

review article

1 reference

title

Therapeutic drug monitoring of immunosuppressant drugs (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

D W Holt

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

language of work or name

English

0 references

publication date

1 April 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Clinical Pharmacology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

339-350

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

Therapeutic drug monitoring of antimetabolic cytotoxic drugs

5 December 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Clinical pharmacokinetics of mycophenolate mofetil

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Clinical pharmacokinetics in the 21st century. Does the evidence support definitive outcomes?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Xenotransplantation: problems and prospects

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Prospective investigations of concentration-clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Sirolimus in transplantation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Disposition of basiliximab, an interleukin-2 receptor monoclonal antibody, in recipients of mismatched cadaver renal allografts

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

SDZ RAD, a new rapamycin derivative: pharmacological properties in vitro and in vivo

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Ten years of Orthoclone OKT3 (muromonab-CD3): a review

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Sirolimus: a new agent for clinical renal transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Target concentration strategy for cyclosporin monitoring

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

New insights into therapy with monoclonal antibodies in allograft transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Immunosuppressive protocols for renal transplantation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Relationship of whole-blood FK506 concentrations to rejection and toxicity in liver and kidney transplants.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Monitoring antithymocyte globulin in renal transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Muromonab CD3: a reappraisal of its pharmacology and use as prophylaxis of solid organ transplant rejection

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Clinical pharmacokinetics of tacrolimus

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Toxic effects of immunosuppressive drugs: mechanisms and strategies for controlling them.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Pharmacokinetics of mycophenolate mofetil (RS61443): a short review.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Neoral in liver transplantation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Consensus guidelines for therapeutic drug monitoring of rapamycin: report of the consensus panel.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Cyclosporin A: analytical methodology and factors affecting therapeutic drug monitoring

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Consensus document: therapeutic monitoring of tacrolimus (FK-506).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Therapeutic drug monitoring of tacrolimus in clinical transplantation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The history of cyclosporin A (Sandimmune) revisited: another point of view

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The IL-2 receptor complex: its structure, function, and target genes

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The IL-2/IL-2 receptor system: a current overview

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Bayesian and threshold probabilities in therapeutic drug monitoring: when can serum drug concentrations alter clinical decisions?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Use of therapeutic drug monitoring in pharmacoeconomics.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Immunosuppressive and other effects of mycophenolic acid and an ester prodrug, mycophenolate mofetil

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Sandimmun neoral pharmacokinetics: impact of the new oral formulation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

EMIT cyclosporine assay: development of an application protocol for Technicon AXON System.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Methodological and clinical aspects of cyclosporin monitoring: report of the Association of Clinical Biochemists task force

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Concentration-controlled trials. What does the future hold?

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Optimizing the use of cyclosporine in renal transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Modes of action of FK506, cyclosporin A, and rapamycin.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The present position and future prospects of organ transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Immunosuppression and clinical organ transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Mycophenolic acid (NSC-129185): preliminary clinical trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Organ transplantation. The present position and future prospects of organ transplantation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The influence of haematocrit on blood cyclosporin measurements in vivo.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Therapeutic drug monitoring

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Blood cyclosporin concentrations and renal allograft dysfunction

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Cyclosporin assay techniques. Accuracy and reproducibility variables impacting on measurements

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Canadian Consensus Meeting on cyclosporine monitoring: report of the consensus panel.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Consensus document: Hawk's Cay meeting on therapeutic drug monitoring of cyclosporine

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The discovery and development of cyclosporine (Sandimmune).

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Quality assurance for cyclosporin assays in body fluids.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Lymphocyte-Selective Cytostatic and Immunosuppressive Effects of Mycophenolic Acid in Vitro: Role of Deoxyguanosine Nucleotide Depletion

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Cyclosporin monitoring: its role in autoimmune indications

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

The mechanism of action of cyclosporin A and FK506

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Biological effects of cyclosporin A: A new antilymphocytic agent

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Isolation of a human thiopurine S-methyltransferase (TPMT) complementary DNA with a single nucleotide transition A719G (TPMT*3C) and its association with loss of TPMT protein and catalytic activity in humans.

28 July 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Survey of the Italian Registry of Renal Biopsies. Frequency of the renal diseases for 7 consecutive years. The Italian Group of Renal Immunopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic/pharmacodynamic relationship for mycophenolic acid and suppression of rejection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

A phase I trial of humanized anti-interleukin 2 receptor antibody in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Disposition and immunodynamics of basiliximab in liver allograft recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Treatment of lupus nephritis--the advantages of a flexible approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

New immunologically non-specific immunosuppressive agents dictate changes in standard protocols for renal transplant management.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

A logistic-regression model provides novel guidelines to maximize the anti-acute rejection properties of cyclosporine with a minimum of toxicity

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Pharmacokinetics of a new oral formulation of cyclosporine in liver transplant recipients.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2014241

Alternative pathway complement activation induces proinflammatory activity in human proximal tubular epithelial cells

30 October 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2125.1999.00911.X

Quality assessment issues of new immunosuppressive drugs and experimental experience

21 January 2018

1 reference

12 December 2020

Mycophenolate mofetil for transplantation: new drug, old problems?

1 reference

12 December 2020

Cyclosporine plasma levels six hours after oral administration. A useful tool for monitoring therapy

1 reference

12 December 2020

Pharmacokinetics and immunodynamics of chimeric IL-2 receptor monoclonal antibody SDZ CHI 621 in renal allograft recipients

1 reference

12 December 2020

The pharmacokinetics of Sandimmun Neoral: a new oral formulation of cyclosporine

1 reference

12 December 2020

Prolonged action of a chimeric interleukin-2 receptor (CD25) monoclonal antibody used in cadaveric renal transplantation

1 reference

12 December 2020

Calcineurin activity is only partially inhibited in leukocytes of cyclosporine-treated patients

1 reference

12 December 2020

An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group

1 reference

12 December 2020

Effect of Metabolic Inhibitors on Cyclosporine Pharmacokinetics Using a Population Approach

1 reference

12 December 2020

Sample pretreatment to minimize interference from whole blood in the radioimmunoassay for cyclosporine

1 reference

12 December 2020

Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?

1 reference

12 December 2020

Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group

1 reference

12 December 2020

An abbreviated area-under-the-curve monitoring for tacrolimus in patients with liver transplants

1 reference

12 December 2020

Measurement of cyclosporine: methodological problems

1 reference

12 December 2020

Intra- and interindividual variation in the pharmacokinetics of tacrolimus (FK506) in kidney transplant recipients--importance of trough level as a practical indicator

1 reference

12 December 2020

External quality assessment scheme for cyclosporin in body fluids

1 reference

12 December 2020

Limit of quantification (functional sensitivity) of the new IMx Tacrolimus II microparticle enzyme immunoassay

1 reference

12 December 2020

Cyclosporin whole blood immunoassays (AxSYM, CEDIA, and Emit): a critical overview of performance characteristics and comparison with HPLC

1 reference

12 December 2020

Prolonged immunosuppressive effect and minimal immunogenicity from chimeric (CD25) monoclonal antibody SDZ CHI 621 in renal transplantation

1 reference

12 December 2020

Monitoring of TPMT in heart transplant recipients under immunosuppressive therapy with azathioprine

1 reference

12 December 2020

Efficacy and side-effects of cyclosporine dose monitoring with levels 6 h after the morning dose in heart transplant patients

1 reference

12 December 2020

Tacrolimus quality assessment

1 reference

12 December 2020

The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation

1 reference

12 December 2020

Cyclosporine dose adjustment using levels obtained six hours after the morning dose: effect on side effects in patients with autoimmune diseases

1 reference

12 December 2020

Japanese study of FK 506 on kidney transplantation: the benefit of monitoring the whole blood FK 506 concentration. Japanese FK 506 Study Group

1 reference

12 December 2020

Preclinical evaluation of a new immunosuppressive agent, FTY720

1 reference

12 December 2020

Therapeutic drug monitoring of mycophenolic acid: comparison of HPLC and immunoassay reveals new MPA metabolites

1 reference

12 December 2020

Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid

1 reference

12 December 2020

Mycophenolate mofetil

1 reference

12 December 2020

1 reference

12 December 2020

Reduced cyclosporine absorption preceded acute allograft rejection in a child with a liver transplant

1 reference

12 December 2020

How to measure cyclosporin

1 reference

12 December 2020

OKT3 serum levels as a guide for prophylactic therapy: a pilot study in kidney transplant recipients

1 reference

12 December 2020

Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression in renal transplant recipients

1 reference

12 December 2020

Generic substitution for cyclosporine: what should we be looking for in new formulations?

1 reference

12 December 2020

Rapamycin: distribution, pharmacokinetics and therapeutic range investigations: an update

1 reference

12 December 2020

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

12 December 2020

OKT3 prophylaxis in kidney transplant recipients: drug monitoring by flow cytometry

1 reference

12 December 2020

P70 S6 kinase assay: a pharmacodynamic monitoring strategy for rapamycin; assay development

1 reference

12 December 2020

A limited sampling strategy for the measurement of cyclosporine AUC

1 reference

12 December 2020

Cyclosporin pharmacokinetics in heart-lung transplant recipients with cystic fibrosis. Effects of pancreatic enzymes and ranitidine

1 reference

12 December 2020

Therapeutic monitoring of mycophenolic acid. A consensus panel report

1 reference

12 December 2020

Role of immunophilins in therapeutic drug monitoring of immunosuppressive drugs

1 reference

12 December 2020

Pharmacodynamic monitoring of immunosuppressive drugs

1 reference

12 December 2020

Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry

1 reference

12 December 2020

Influence of treatment with cyclosporine, azathioprine and steroids on chronic allograft failure. The Collaborative Transplant Study

1 reference

12 December 2020

Cyclosporine monitoring with levels 6 hours after the morning dose in patients with noninfectious uveitis

1 reference

12 December 2020

Calibration of the CYCLO-Trac SP cyclosporine radioimmunoassay

1 reference

12 December 2020

Changing stable heart transplant recipients from Sandimmune to Neoral

1 reference

12 December 2020

Total testing process applied to therapeutic drug monitoring: impact on patients' outcomes and economics

1 reference

12 December 2020

The United Kingdom Cyclosporin Quality Assessment Scheme

1 reference

12 December 2020

Immunological monitoring of azathioprine treatment in multiple sclerosis patients

1 reference

12 December 2020

Mycophenolate mofetil-based, cyclosporine-free induction and maintenance immunosuppression: first-3-months analysis of efficacy and safety in two cohorts of renal allograft recipients

1 reference

12 December 2020

Predicting patients' exposure to cyclosporin

1 reference

12 December 2020

Monitoring new immunosuppressive agents. Are the methods adequate?

1 reference

12 December 2020

Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group

1 reference

12 December 2020

10.1046/J.1365-2125.1999.00911.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10233195%20AND%20SRC:MED&resulttype=core&format=json